Introduction

Valkyrie Pharmaceutical Primobolan 100 is presented in a 10-milliliter multidose vial, labeled to contain 100 milligrams of methenolone enanthate per milliliter. As part of its ongoing mission to promote harm reduction, AnabolicLab procured samples of this product from a European-based internet source. These samples were purchased between July 15, 2016, and August 30, 2016, and submitted to SIMEC AG, an internationally recognized analytical laboratory, for testing.

AnabolicLab funded the analysis, which included HPLC-UV quantitative dosage testing as well as microbiological safety testing, including total aerobial microbiological count (TAMC) and total yeast and mold count (TYMC). The results confirmed that the product slightly exceeded its label claim, indicating a minor overdose of the active ingredient. By providing this transparent analysis, AnabolicLab aims to empower consumers with reliable information about product quality.

Testing Results and Authentication

The samples were received by SIMEC AG on August 30, 2016, and the report was finalized on September 26, 2016.

The product was identified with:

• Batch Number: XFR3666
• Expiration Date: March 2018

Product Overview

• Manufacturer: Valkyrie Pharmaceutical
• Product Name: Primobolan 100
• Active Ingredient: Methenolone Enanthate
• Batch Number: XFR3666
• Expiration Date: March 2018
• Delivery Method: Injectable (10-milliliter multidose vial)
• Specification: 100 mg/ml methenolone enanthate

Sample Acquisition and Testing

• Date Purchased: Between July 15, 2016, and August 30, 2016
• Source: European-based internet supplier
• Product Submitted By: AnabolicLab
• Analysis Paid For By: AnabolicLab
• Analysis Performed By: SIMEC AG
• Date Received by Lab: August 30, 2016
• Date Report Completed: September 26, 2016

Testing Results

Quantitative Dosage Testing (HPLC-UV):

• Claimed Dosage: 100 mg/ml methenolone enanthate
• Measured Dosage: 106.2 mg/ml methenolone enanthate
• Accuracy: 106.2% (exceeding the label claim)
• Variance: +6.2% (measured dosage exceeded label claim by 6.2%)

Microbiological Contamination Testing:

• Total Aerobial Microbiological Count (TAMC): No contamination detected
• Total Yeast and Mold Count (TYMC): No contamination detected

Summary

The analysis of Valkyrie Pharmaceutical Primobolan 100 revealed a measured concentration of 106.2 mg/ml methenolone enanthate, exceeding the label claim by 6.2%. This minor overdose suggests an acceptable level of manufacturing variability. The microbiological safety testing confirmed that no contamination was present, supporting the product’s safety for its intended use. By publishing these findings, AnabolicLab promotes transparency and accountability in the anabolic steroid market, helping consumers make informed decisions.

Commitment to Harm Reduction

AnabolicLab remains dedicated to reducing harm by conducting independent analyses and publishing reliable results. This commitment ensures that consumers can verify product quality, minimizing risks associated with mislabeled or contaminated products while encouraging greater accountability within the market.

Disclaimer
The information provided here is for educational and harm reduction purposes only. AnabolicLab does not endorse or promote the use of anabolic steroids or other controlled substances.

Discuss the Valkyrie Pharmaceutical Primobolan 100 lab test results on the AnabolicLab Forum.

(The following images are photographs of the actual product that was submitted for testing.)

Valkyrie Pharmaceutical Primobolan 100 Dosage, Microbiological Lab Results [PDF]
Does Valkyrie Pharmaceutical Primobolan 100 really contain 100 milligrams of methenolone enanthate in each milliliter of solution? HPLC-UV, TAMC, TYMC (September 26, 2016) …

Size	954.43 KB
Downloaded	804 times
Last Updated	September 29, 2016
Download

---